Navigation Links
Decongestant Exposure Needs Closer Look
Date:12/5/2008

Study says pseudoephedrine for kids under 2 poses toxicity issues because of use patterns

FRIDAY, Dec. 5 (HealthDay News) -- Exposure to the decongestant pseudoephedrine, found in many cough, cold and allergy medicines, appears to be common among children in the United States.

This is especially true among children younger than 2, who have the highest risk for toxicity and for whom safe dosing recommendations are lacking, say researchers at Boston University's Slone Epidemiology Center.

Pseudoephedrine has been linked to deaths and adverse events in young children, but the absolute risks posed to children by this decongestant are difficult to determine, because the number of children exposed to it and typical patterns of use haven't been known, the researchers explained.

They analyzed data from 1999 through 2006 on pseudoephedrine use among 4,267 children, aged birth to 17 years, included in a national telephone survey of medication use in the United States, and found that 4.9 percent of the children took pseudoephedrine in a given week. Use of the decongestant was highest among children younger than 2 years old (8.1 percent).

The researchers found that 16 children (7.5 percent of users) took more than one pseudoephedrine-containing product within the same week, including six children younger than 2. Of the pseudoephedrine products used by children, most were multiple-ingredient liquids (58.9 percent) and multiple-ingredient tablets (24.7 percent). The study also found that 52 children (25 percent of users) took pseudoephedrine for longer than one week, including seven children younger than 2.

The use of pseudoephedrine by children was much lower in 2006 (2.9 percent) than in 1999-2005 (5.2 percent), likely due to a new law that reduced availability of the decongestant, the researchers said.

The study was published in the December issue of Pediatrics.

"Pseudoephedrine exposure, mostly in the form of multiple-ingredient products, is common among U.S. children and needs to be monitored closely because of the potential for this medication to cause harm, particularly to children under 2," concluded lead author Dr. Louis Vernacchio, an assistant professor of epidemiology and pediatrics at Boston University School of Medicine.

More information

MedlinePlus has more about pseudoephedrine.



-- Robert Preidt



SOURCE: Boston University, news release, Dec. 1, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Decongestant in OTC Cold Remedies Effective: FDA Panel
2. Acting Surgeon General Announces National Initiatives to Protect Children by Reducing Exposure to Secondhand Smoke
3. Penn School of Medicine receives $2.3 million to study biomarkers of cigarette smoke exposure
4. Teamsters Applaud Passage of Legislation to Protect Workers From Diacetyl Exposure
5. R rating might be unlikely to affect teens exposure to smoking in movies
6. Occupational exposures may be linked to death from autoimmune disease
7. Low Lead Exposures Can Hurt Kidneys
8. Exposure to sunlight may decrease risk of advanced breast cancer by half
9. Firing clay in unvented kilns may be a source of exposure to dioxins
10. VIDEO from Medialink and EcoQuest: New Technology Reduces Exposure to MRSA Staph
11. Fetal Exposure to Arsenic Affects Genes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Decongestant Exposure Needs Closer Look
(Date:10/13/2017)... ... ... PurhealthRX , a leading Health and Nutrition Company, is announcing the ... spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the amount ... into liquid products, while reducing costs to end users. , The team of researchers ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... MENLO PARK, Calif. , Oct. 11, 2017 /PRNewswire/ ... a national scientific team that developed an innovative way ... and quantity of the delivery of new drugs. ... the 2017 Fall Clinical Dermatology Conference will show how ... Massachusetts General Hospital, Harvard Medical School used a suite ...
(Date:10/10/2017)... Oct. 10, 2017   West Pharmaceutical Services, Inc. ... for injectable drug administration, today shared the results of ... for improving the intradermal administration of polio vaccines. The ... Summit in May 2017 by Dr. Ondrej Mach ... World Health Organization (WHO), and recently published in the ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
Breaking Medicine Technology: